
As long as the price is ok for u I will recommend buy.. Medical sectors are very stable and biosensors a very profitable company
Just a few cents on view...
Just a few cents on view...
On Thursday, Biosensors trend sideways and closed at $1.225 with HIGH volume of 5.88 million shares traded.
RSI & MACD are neutral as RSI trend sideways.
Important Resistance of Biosensors: $1.27
Immediate Support of Biosensors: $1.215
Currently prices are supported by 100 days MA.
Since 26/July, prices have been consolidating  ...........        READ MORE
 
anyone vested in this counter? if have, at what prices you bought?
correction. Meant to be -Be patient, so far the results have not disappointed us....
allright ( Date: 08-Sep-2012 21:10) Posted:
|
DBS Vickers-Pick growth stocks with imminent catalysts and
strong visibility. As highlighted in our last SMC issue, we
continue to favour stocks with tangible earnings growth.
Here, we pick stocks with FY13F growth higher than the
12% average expected of our basket of SMCs. As such,
we reiterate our Buy calls for Bumitama and Tiger Airways.
We have added Hi-P for the strong boost to its earnings
from the market’s almost insatiable demand for Apple
products. We also like Biosensors for its 30% earnings
growth and strong competitive advantages. With the Oil &
Gas sector reporting record order wins and oil prices still
running up, we believe interest would rotate from bigger
market cap O& G stocks to smaller cap O& G beneficiaries
with strong order books and earnings visibility such as
Nam Cheong and ASL Marine. Within the O& G sub-space,
we pick undervalued LNG service provider AusGroup at
< 5x FY13 PE for 30% growth backed by secured orders.
allright ( Date: 08-Sep-2012 21:10) Posted:
|
Be patient. So far this company has not failed to disappoint us viz their results. As for the share price - yes its   a disappointment considering the fact that so many analysts call a buy on this share. 
 
This is just my view...... I think it is no point looking at this stock for now as the big boy insiders has internally fixed price at about $ 1.22 or around there till they announce their M& A using the newly issued shares. It only take about 2 million sell order to bring the price swiftly down to $1.215  ., just too easy for them. The big boy insider`s game plan is just to  bash down all upward attempts, so far already happened 3 times.  So no need to watch this stock till probably Oct.2nd Quater result is announced.     
iPunter ( Date: 05-Sep-2012 19:09) Posted:
|
Next stop may be 1.10... but don't " mau " big...  

cashiertan ( Date: 05-Sep-2012 17:32) Posted:
|
burst downwards. technically is correct just that the market now show us where it wants to head.
Got tighter and tighter.......... when going to burst?/?/?/?/?/  

TradeChancellor ( Date: 04-Sep-2012 16:17) Posted:
|
Bollinger bands very tight now... breakout should happen soon...
Wish List:
For Shangdong Weigao who currently owns 21.6% of Biosensors to fully acquire the company at $2.00 ? 
Thanks Infancy Bird. I also   heard another house Religare initiates a buy at $1.48 (I don't have the report)
  and yesterday this announcement on SGX
|
infancybird ( Date: 25-Aug-2012 15:34) Posted:
|
BIOSENSORS, HI-P, k1 VENTURES: What analysts now say... |
Friday, 24 August 2012 12:32
Excerpts from latest analyst reports..... OCBC says BIOSENSORS is its preferred pick of healthcare stocks Analyst: Wong Teck Ching Andy ![]() Recoomendations on Biosensors. Compiled by NextInsight
Under our Healthcare sector coverage, both Raffles Medical Group (RMG) and Biosensors International Group (BIG) continued to deliver YoY revenue and earnings growth during the recently concluded 2QCY12 results period, although the former’s PATMI was slightly below our expectations. Looking ahead, we believe that the strong balance sheets of RMG and BIG (net cash of S$63.9m and US$306.7m, respectively) would allow them to bolster their expansion plans despite the ongoing macroeconomic uncertainties. In our view, the major risk for the Healthcare sector stems from margin pressure, arising from higher manpower and consumables costs and mandatory price cuts for drugs and stents. Nevertheless, we believe that RMG and BIG would be able to meet our expectations for core earnings growth of 11.7% and 25.0% respectively, for their current fiscal year. Maintain OVERWEIGHT on the Healthcare sector, with BIG [BUY FV: S$1.81] remaining as our preferred pick. |
infancybird ( Date: 08-Aug-2012 12:01) Posted:
|
It will when the market continues its uptrend.   Dow is expected to climb beyond 14K, so possibly we can see all stocks making new highs.
when is it going back to test its hi's?? 
Steadily moving into the 1,28- 1.36 range. Likely this afternoon or next week.
Ready for  a breakout of  a triangle?
In my opinion, the price is going to be range bound( insider BB  want this price ) b/w $1.20 to 1.25, not lower nor higher till the announcement of the use of their   newly issued shares for their M& A . No need to watch this counter for the time being.     
bishan22 ( Date: 01-Aug-2012 11:07) Posted:
|